Hospital outcomes for young adults with COVID-19

Brian S Williams1,2,3, Thomas M Piasecki1,4, Michael C Fiore1,4

  • 1Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health.

Global Epidemiology
|August 5, 2024
PubMed

Insights

Young adults hospitalized with COVID-19 experienced significant illness, with cancer history increasing death risk. Vaccination offered protection against severe outcomes like ICU admission.

Area of Science:

  • Infectious Diseases
  • Public Health
  • Epidemiology

Background:

  • Older adults face higher COVID-19 risks, but young adult outcomes are less understood.
  • Young adults have experienced high COVID-19 infection rates.
  • Comorbidities exacerbate severe COVID-19 outcomes.

Purpose of the Study:

  • To determine outcomes for young adults hospitalized with COVID-19.
  • To assess rates of oxygen use, mortality, ICU admission, and intubation.
  • To identify factors associated with adverse COVID-19 outcomes in young adults.

Main Methods:

  • Retrospective cohort study using EHR data from 21 US health systems.
  • Included 18-29-year-olds hospitalized with COVID-19 (March 2020 - January 2022).
  • Oxygen need identified symptomatic cases; outcomes compared between symptomatic and asymptomatic groups.

Main Results:

  • 35% of 9871 hospitalized young adults required oxygen.
  • Mortality: 2.6%; ICU admission: 27.7%; Intubation: 15.8%.
  • Cancer history increased death odds (2.1x); vaccination reduced ICU odds (>40%).

Conclusions:

  • COVID-19 caused significant morbidity and mortality in hospitalized young adults needing oxygen.
  • A history of cancer was linked to a higher risk of death.
  • Vaccination demonstrated a protective effect against severe COVID-19 illness.
Abstract

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
193
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
192
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
184
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
126
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
167
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
314